We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Updated EMA Antibiotic Development Guidelines Push Streamlined Filings
Updated EMA Antibiotic Development Guidelines Push Streamlined Filings
November 11, 2013
Drugmakers seeking approval in the EU for antibiotics that target multidrug-resistant infections will be allowed to use limited data to move products more quickly to market under new European Medicines Agency (EMA) guidelines posted Nov. 7.